De standaard 'Diabetes mellitus type 2' (tweede herziening) van het Nederlands Huisartsen Genootschap; reactie vanuit de interne geneeskunde

- The revised guideline ‘Diabetes mellitus type 2’ contains several improvements. The HbA_1c target level has been lowered to 7 or less. The universal first step in oral therapy has become metformin. The target level for the treatment of hypertension is now a systolic pressure below 140 mmHg. Statins should be prescribed to almost every patient. Finally, ACE-inhibitors are now suggested for all patients with microalbuminuria and hypertension. Some choices made in the present guideline are not evidence-based, e.g. the advice to prescribe pioglitazone to patients with both a body mass index above 27 kg/m2 and cardiovascular disease, but without heart failure. Still, in general, the updated guideline is an important document which has been greatly improved in comparison to the former one.

Ned Tijdschr Geneeskd. 2006;150:2235-7